CYPRESS CAPITAL GROUP – Eli Lilly and Company Transaction History
CYPRESS CAPITAL GROUP portfolio value:
$23.70M
portfolio value
CYPRESS CAPITAL GROUP quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.87% | -2.95K shares | -1.02M | $323.35 | 73.31K |
| Q2 2022 | share | Decrease | -5.37% | -4.32K shares | 1.64M | $324.23 | 76.26K |
| Q1 2022 | share | Decrease | -0.28% | -229 shares | 754K | $286.37 | 80.58K |
| Q4 2021 | share | Decrease | -0.99% | -805 shares | 3.46M | $277.25 | 80.81K |
| Q3 2021 | share | Decrease | -0.63% | -515 shares | 7K | $230.3 | 81.62K |
| Q2 2021 | share | Decrease | -0.58% | -482 shares | 3.41M | $228.04 | 82.13K |
| Q1 2021 | share | Decrease | -1.19% | -994 shares | 1.31M | $184.81 | 82.61K |
| Q4 2020 | share | Increase | +2.34% | 1.90K shares | 2.02M | $166.32 | 83.61K |
| Q3 2020 | share | Decrease | -0.89% | -730 shares | -1.44M | $145.05 | 81.70K |
| Q2 2020 | share | Decrease | -0.76% | -629 shares | 2.01M | $160.1 | 82.43K |
| Q1 2020 | share | Decrease | -3.44% | -2.96K shares | 216K | $134.64 | 83.06K |
| Q4 2019 | share | Increase | +0.02% | 14 shares | 1.68M | $126.91 | 86.02K |
| Q3 2019 | share | Decrease | -1.03% | -895 shares | -10K | $107.36 | 86.00K |
| Q2 2019 | share | Increase | +2.36% | 2.00K shares | -1.38M | $105.74 | 86.90K |
| Q1 2019 | share | Decrease | -2.24% | -1.94K shares | 968K | $123.17 | 84.90K |
| Q4 2018 | share | Increase | +5.60% | 4.60K shares | 1.22M | $109.26 | 86.84K |
| Q3 2018 | share | Increase | +0.69% | 561 shares | 1.85M | $100.8 | 82.24K |
| Q2 2018 | share | Increase | +0.80% | 650 shares | 701K | $79.72 | 81.68K |
| Q1 2018 | share | Decrease | -4.24% | -3.58K shares | -877K | $71.78 | 81.03K |
| Q4 2017 | share | Decrease | -3.54% | -3.10K shares | -357K | $77.79 | 84.61K |
| Q3 2017 | share | Decrease | -0.67% | -590 shares | 235K | $78.29 | 87.72K |
| Q2 2017 | share | Decrease | -1.94% | -1.75K shares | -307K | $74.85 | 88.31K |
| Q1 2017 | share | Increase | +3.51% | 3.05K shares | 1.17M | $76 | 90.06K |
| Q4 2016 | share | Increase | +2.61% | 2.21K shares | -406K | $66.02 | 87.00K |
| Q3 2016 | share | Decrease | -1.28% | -1.1K shares | 41K | $71.57 | 84.79K |
| Q2 2016 | share | Decrease | -1.30% | -1.12K shares | 498K | $69.79 | 85.89K |
| Q1 2016 | share | Decrease | -2.26% | -2.01K shares | -1.23M | $63.39 | 87.01K |